Literature DB >> 9500876

Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors.

N S Gauthier1, J P Headrick, G P Matherne.   

Abstract

Adenosine, acting via A1 receptors, modulates heart rate and contractility, and provides myocardial protection during times of stress. A transgenic model of cardiac A1 overexpression was produced and it demonstrated cardiac protection from ischemia. Since A1 receptor stimulation can inhibit contractility under some conditions, the present study was undertaken to determine the effects of transgenic A1 overexpression on intrinsic contractility and the response to catecholamine stimulation. Isolated working mouse hearts were subjected to volume- and pressure-loading protocols to assess intrinsic contractility, and isoproterenol infusions to assess catecholamine response. Basal heart rates were lower in transgenic (Trans) hearts than controls (Ctrl), but with pacing baseline cardiac function and contractility (as measured by +dP/dt) were similar. Volume and pressure loading of Ctrl and Trans hearts were also similar along the entire range tested. No differences were seen in the sensitivity to isoproterenol infusion, but at maximal doses there was a decrease in maximum +dP/dt in Trans hearts compared to Ctrl (maximum +dP/dt 152 +/- 6% baseline for Ctrl, 131 +/- 2% baseline for Trans, P < 0.05). In summary, overexpression of A1 receptors does not produce untoward effects on ventricular function or sensitivity to catecholamine stimulation, but does dampen the contractile response at high doses of catecholamines. These data suggest that even with 1000-fold overexpression of A1 adenosine receptors, adenosine plays little or no role in regulating intrinsic myocardial contractility in the sympathectomized isolated working heart, only modulating contractility as the heart becomes stressed during exposure to higher catecholamine levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500876     DOI: 10.1006/jmcc.1997.0585

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

2.  Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.

Authors:  Tung O Chan; Hajime Funakoshi; Jianliang Song; Xue-Qian Zhang; JuFang Wang; Paul H Chung; Brent R DeGeorge; Xue Li; Jin Zhang; David E Herrmann; Maura Diamond; Eman Hamad; Steven R Houser; Walter J Koch; Joseph Y Cheung; Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

3.  Functional studies in atrium overexpressing A1-adenosine receptors.

Authors:  J Neumann; U Vahlensieck; P Boknik; B Linck; H Lüss; F U Müller; G P Matherne; W Schmitz
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.

Authors:  Richard G Black; Yiru Guo; Zhi-Dong Ge; Sidney S Murphree; Sumanth D Prabhu; W Keith Jones; Roberto Bolli; John A Auchampach
Journal:  Circ Res       Date:  2002-07-26       Impact factor: 17.367

5.  Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos.

Authors:  Satish K Ghatpande; Charles J Billington; Scott A Rivkees; Christopher C Wendler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-03

6.  Arrhythmia and sudden death associated with elevated cardiac chloride channel activity.

Authors:  L Ye; W Zhu; P H Backx; M A Cortez; J Wu; Y-H Chow; C McKerlie; A Wang; L-C Tsui; G J Gross; J Hu
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

Review 7.  Adenosine and the Cardiovascular System: The Good and the Bad.

Authors:  Régis Guieu; Jean-Claude Deharo; Baptiste Maille; Lia Crotti; Ermino Torresani; Michele Brignole; Gianfranco Parati
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

8.  Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo.

Authors:  Michael Koeppen; Tobias Eckle; Holger K Eltzschig
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.